Why Moderna says its vaccine efficacy in children is better than it seems

(NEW YORK) -- Moderna's bid for FDA authorization for its two-dose vaccine for children comes with lower efficacy against infection than previous vaccines, but the company and some experts say it will offer strong protection against illness from tougher strains like Omicron.The pharmaceutical company submitted...